Skip to content
sellWeak cluster of 310b5-1 plan

John Q Doyle sold $5.0M of MRSH

President and CEO at MARSH & MCLENNAN COMPANIES, INC.. 21,080 shares at an average of $237.05, traded Mar 3, 2025, filed Mar 4, 2025.

Warning score
35
Value
$5.0M
21,080 shares
Holdings after
87,681
-19% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    CEO
    +25
  • Trade size
    $5.0M at market
    +25
  • Share of holdings sold
    Sold 19% of holdings
    +5
  • Cluster
    3 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

MRSHOct 9, 2026 · close 175.76
Since filing Mar 4, 2025: -23.2%SPY +37.6% · excess -60.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001127602-25-007860, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 28, 2025MOption exercise
Common Stock10b5-1
+26,426$0.00$0101,172Mar 4, 2025
Feb 28, 2025FTax withholding
Common Stock10b5-1
-13,491$233.74$3.2M87,681Mar 4, 2025
Mar 3, 2025MOption exercise
Common Stock10b5-1
+21,080$63.09$1.3M108,761Mar 4, 2025
Mar 3, 2025SOpen-market sale
Common Stock10b5-1
-21,080$237.05$5.0M87,681Mar 4, 2025
Feb 28, 2025MOption exercise
Restricted Stock Unitsderivative10b5-1
-26,426$0.00$00Mar 4, 2025
Mar 3, 2025MOption exercise
Stock Options (Right to Buy)derivative10b5-1
-21,080$0.00$063,238Mar 4, 2025

Related signals

Other insiders at MARSH & MCLENNAN COMPANIES, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
25Weak
MRSHsell 2
MARSH & MCLENNAN COMPANIES, INC.
Katherine Brennan
SVP and General Counsel
$225k
1,197 shares
-14%
28Weak
MRSHsell 210b5-1
MARSH & MCLENNAN COMPANIES, INC.
John Q Doyle
President and CEO
$3.1M
16,656 shares
-12%
20Weak
MRSHsell10b5-1
MARSH & MCLENNAN COMPANIES, INC.
John Q Doyle
President and CEO
$4.9M
21,080 shares
-19%
4Weak
MRSHsell10b5-1
MARSH & MCLENNAN COMPANIES, INC.
Paul Beswick
SVP, Chief Information Officer
$550k
2,237 shares
-14%
55Moderate
MRSHsell 310b5-1
MARSH & MCLENNAN COMPANIES, INC.
Dean Michael Klisura
President & CEO, Guy Carpenter
$1.7M
7,121 shares
-25%
60Notable
MRSHsell 3
MARSH & MCLENNAN COMPANIES, INC.
John Jude Jones
Chief Marketing Officer
$2.5M
10,824 shares
-120%
40Moderate
MRSHsell
MARSH & MCLENNAN COMPANIES, INC.
Oscar Fanjul
director
$1.1M
5,000 shares
-10%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

John Q Doyle sold $5.0M of MRSH | InsiderTell